Observational Study to Describe the Impact of Treatment Combinations with Daratumumab Versus Other Alternative Regimens in Patients with Relapsed/refractory Multiple Myeloma. Spain Real World Evidence (RWE) Data. GeminiS Study
Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia（2019）
Key words
monoclonal antibody,real-world evidence,Relapsed Refractory MM
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined